BryoLogyx is Drug Discovery in United States that focus on HIV cure business. Founded in 2017. They cover business area such as developer, cancer immunotherapy, HIV cure, bryostatin technology, cell, heighten immune recognition, clearance, immunotherapeutic agent, host immune mechanism, their technology, immuno-oncology agent, immune checkpoint inhibitor, monoclonal antibody.
2017
( 7 years old in 2024 )
HIV Cure
-
2485 Holly Oak Drive
Danville, CA 94506
United States
Private
developercancer immunotherapyHIV curebryostatin technologycellheighten immune recognitionclearanceimmunotherapeutic agenthost immune mechanismtheir technologyimmuno-oncology agentimmune checkpoint inhibitormonoclonal antibody
* We use standard office opening hours in near BryoLogyx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BryoLogyx is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), BryoLogyx business is focusing on HIV Cure.
BryoLogyx headquarter office and corporate office address is located in 2485 Holly Oak Drive Danville, CA 94506 United States.
BryoLogyx was founded in United States.
In 2024, BryoLogyx is currently focus on HIV cure sector.
Above is snippet of Google Trends for "HIV cure" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BryoLogyx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
